Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat

References

• Alberts D. S., Peng Y. M., Chen G., Moon T. E., Cetas T. C., Heschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse model. Journal of the Motional Cancer Institute 1980; 65: 455–460
   PubMed Web of Science ®Google Scholar
• Barlogie B., Corry P. M., Drewinko B. In vitro therinocheinotlierapy of- human coslon canccr cells with cis-dichloroplatimum(II) and mitoniycin C. Cancer Reseasrarch 1980; 40: 1136–11389
   PubMedGoogle Scholar
• Baba H., Siddik Z. H., Strebel F. R., Jenkins G. N., Bull J. M. C. Increased therspeutic gain of combined cis-dianiniinedichloroplatinuni(II) and whole body hyperthermia by optimal heat/drug scheduling. Cancer Research 1989; 49: 7041–7044
   PubMed Web of Science ®Google Scholar
• Bulger R. E., Dobyan D. C. Proliferative lesions found in rat kidneys after single dose of cisplatin. Journal of the National Cancer Institute 1984; 73: 1235–1242
   PubMedGoogle Scholar
• Choie D. D., Longnecker D. S., Del Campo A. A. Acute and chronic cisplatin nephropathy in rats. Laboratory Investigations 1981; 44: 397–402
   PubMed Web of Science ®Google Scholar
• Cohen J. D., Robins H. I., Schmitt C. L. Interactions of hyperthermia with carboplatin, cisplatin, and ctiposide in hunian leukemia cells. in vitro. Cancer Letters 1989; 44: 205
   PubMed Web of Science ®Google Scholar
• Dobyan D. C. Long-term consequences of cis-plalinum-induced renal injury: a structural and functional study. Anatomical Record 1985; 212: 239–245
   PubMedGoogle Scholar
• Douple E. B., Strohbehn J. W., De Sieyes D. C., Alborough D. P., Trembly B. S. Theropeutic potentation of cis-dichlorodiammineplatinum(II) and radiation by interstitial microwave hyperthermia in a mouse tumor. Cancer Institute Monograms 1982; 61: 259–262
   Google Scholar
• Engelhart K. Hyperthermia and Drugs. Hyperthermia and the Therapy of Malignant Tumors, C. Sireffer. Springer, Berlin 1987; 136–203
   Google Scholar
• Gerard H., Egorin M. J., Whiteacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (II) and whole body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
   PubMedGoogle Scholar
• Hahn G. M. Thermal enhancement of the actions of anticancer agents. Hyperthermia and Cancer. Plenum, New York 1982; 55–86
   Google Scholar
• Los G., Sminia P., Wondergem J., Mutsaers P. H. A., Haveman J., Ten Bokkel Huinink D., Smals O., Gonzalez Gonzalez D., McVie J. G. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. European Journal of Cancer 1991; 27: 472–477
   PubMed Web of Science ®Google Scholar
• Mella O. Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours. International Journal of Hyperthermia 1985; 1: 171–183
   PubMedGoogle Scholar
• Mella O., Eriksen E., Dahl O., Laerum O. D. Therapy effects and toxicity of hyperthermia and cisplatin in BDIX rats with a transplantable neurogenic tumour BT4A. Hyperthermic Oncology 1984, J. Overgaard. Taylor & Francis, London 1984; 413–416
   Google Scholar
• Page R. L., Thrall D. E., George S. L., Price G. S., Heidner G. L., McEntee M. C., Novotney C. A., Hauck M. L., Dewhirst M. W. Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs. International Journal of Hyperthermia 1992; 8: 161–769
   Google Scholar
• Siddik Z. H., Boxall F. E., Harrap K. R. Flameless atomic absorbtion spectrophotornetric determination of platinum tissues solubilized in hyamine hydroxide. Analytical Biochemistry 1987; 163: 21–26
   PubMed Web of Science ®Google Scholar
• Teicher B. A., Herman T. S., Menon K., Korbutt T. T. Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma. International Journal of Hyperthermia 1992; 8: 783–794
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. C. Effect of cis-Diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Research 1988a; 48: 440–446
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Siddik Z. H., Leygraaf J-W., Strebel F. R., Alonso M., Travis E. L., Bull J. M. C. A comparison of thermal enhancement of cis-diamminedichloroplatinum(II) induced renal and interstitial toxicities by whole body hyperthermia in the rat. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1551–1556
   PubMed Web of Science ®Google Scholar
• Wondergem J., Stephens L. C., Strebel F. R., Baba H., Ohno S., Siddik Z. H., Newman R. A., Bull J. M. C. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Research 1991; 51: 3559–3567
   PubMed Web of Science ®Google Scholar
• Wondergem J., Siddik Z. H., Strebel F. R., Bull J. M. C. Effect of whole body hyperthermia on cisdiamminechloroplatinum(II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio. European Journal of Cancer 1993; 29A: 549–544
   PubMed Web of Science ®Google Scholar
• Wondergem J. F., Strebel R., Siddik Z. H., Newman R. A., Bull J. M. C. The effect of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle. International Journal of Hyperthermia 1988b; 4: 643–654
   PubMed Web of Science ®Google Scholar